Publications by authors named "Jiangshan Tan"

Claim this Profile
T
The sodium-glucose co-transporter 2 inhibitor, empagliflozin, attenuates pulmonary vascular remodelling by inhibiting the phosphorylation of PDGF receptor-β.
Ting-Ting Lyu, Jing-Yang Wang, Jiang-Shan Tan, Tian-Qi Li, Yu-Yuan Shu

Br J Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic risk score and clinical factors predict incident idiopathic pulmonary arterial hypertension.
Song Hu, Jiang-Shan Tan, Shengsong Zhu, Lu Hua, Zhennan Lin

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of spatial and single-cell transcriptomic analysis uncovers cellular and molecular alterations in the hypertensive brain.
Qiannan Gao, Zhiqin Wang, Cui Liu, Haizeng Zhang, Luyun Fan, Jiangshan Tan

Life Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a 10-year predictive model for cardiovascular and metabolic disease risk: insights from a large-scale health examination cohort.
Dejie Wang, Jiang-Shan Tan, Ruihan Liu, Yingjuan Ma, Yugang Han

Open Heart· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Copy number loss Of APP cause thoracic aortic dissection.
Qiannan Gao, Minghui Bao, Jiangshan Tan, Haizeng Zhang, Luyun Fan

Hypertens Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Evidence Linking Lipoprotein(a) to Cardiovascular Disease and the Potential Role of Aspirin: A Mendelian Randomization Study.
Jiangshan Tan, Wei Xu, Song Hu, Jingyang Wang, Lulu Wang

Rev Cardiovasc Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma non-targeted metabolomics unravels the metabolic features of normal trans-right heart.
Xifeng Qian, Yuanrui Deng, Tingting Guo, Xin Huang, Chaowu Yan, Jiangshan Tan

Metabolomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal association between gut microbiota composition and the risk of atrial fibrillation.
Jiangshan Tan, Jingyang Wang, Yanmin Yang, Jun Zhu, Lulu Wang

J Transl Int Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and prognostic value of dementia in atrial fibrillation patients in emergency departments: Insights from a national-wide multicenter registry study.
Hanyang Liang, Jiangshan Tan, Wei Xu, Siqi Lyu, Shuang Wu

Arch Gerontol Geriatr· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the ABC pathway in patients with atrial fibrillation: A machine learning cluster analysis.
Jingyang Wang, Haiyang Bian, Jiangshan Tan, Jun Zhu, Lulu Wang

Int J Cardiol Heart Vasc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Anemia and Prognosis in Patients With Acute Coronary Syndrome and Atrial Fibrillation.
Yuyuan Shu, Lulu Wang, Yimeng Wang, Jiangshan Tan, Han Zhang

Angiology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex versus non-complex percutaneous coronary intervention in patients with atrial fibrillation: a real-world study.
Yimeng Wang, Han Zhang, Jiang-Shan Tan, Lulu Wang, Jingyang Wang

BMC Cardiovasc Disord· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Beta-Blockers and Renin-Angiotensin-Aldosterone System Inhibitors on the Prognosis of Atrial Fibrillation Patients with Chronic Obstructive Pulmonary Disease: A Nation-Wide Registry Study.
Hanyang Liang, Jiangshan Tan, Wei Xu, Siqi Lyu, Shuang Wu

Int J Chron Obstruct Pulmon Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives.
Jiang-Shan Tan, Yixiao Wei, Lingtao Chong, Yanmin Yang, Song Hu

Crit Rev Clin Lab Sci· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex differences in patients with atrial fibrillation and acute coronary syndrome or undergoing PCI: a real-world study.
Yuyuan Shu, Si-Qi Lyu, Jiangshan Tan, Han Zhang, Yimeng Wang

Acta Cardiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal associations between telomere length and pulmonary arterial hypertension: A two-sample Mendelian randomization study.
Ting-Ting Lyu, Jing-Yang Wang, Jiang-Shan Tan, Yan-Min Yang, Yi-Meng Wang

Medicine (Baltimore)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct oral anticoagulants in the treatment of chronic thromboembolic pulmonary hypertension patients: A retrospective cohort study.
Ling-Tao Chong, Song Hu, Ting-Ting Guo, Xin Gao, Jiang-Shan Tan

Respir Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate control or rhythm control in patients with atrial fibrillation and acute coronary syndrome or percutaneous coronary intervention.
Jing-Yang Wang, Ran Mo, Jun Zhu, Jiang-Shan Tan, Lu-Lu Wang

Heliyon· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study.
Yimeng Wang, Yanmin Yang, Lulu Wang, Han Zhang, Jiang-Shan Tan

Thromb J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Application of Artificial Intelligence in Atrial Fibrillation Patients: From Detection to Treatment.
Hanyang Liang, Han Zhang, Juan Wang, Xinghui Shao, Shuang Wu, Jiangshan Tan

Rev Cardiovasc Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic recurrence in patients with pulmonary embolism.
Song Hu, Lei Wang, Jiangshan Tan, Wei Fang, Xinghong Ma

Chin Med J (Engl)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Causal impact of gut microbiota and associated metabolites on pulmonary arterial hypertension: a bidirectional Mendelian randomization study.
Xin Li, Jiang-Shan Tan, Jing Xu, Zhihui Zhao, Qing Zhao

BMC Pulm Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus, glycemic traits, SGLT2 inhibition, and risk of pulmonary arterial hypertension: A Mendelian randomization study.
Jiang-Shan Tan, Yanmin Yang, Jingyang Wang, Yimeng Wang, Tingting Lv

Biosci Trends· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspirin for prevention of cardiovascular disease in patients with high levels of lipoprotein(a): Evidence from two-sample Mendelian randomization analysis.
Jiang-Shan Tan, Wei Xu, Jingyang Wang, Tianqi Li, Lulu Wang

J Evid Based Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic overlap for ten cardiovascular diseases: A comprehensive gene-centric pleiotropic association analysis and Mendelian randomization study.
Zeye Liu, Jing Xu, Jiangshan Tan, Xiaofei Li, Fengwen Zhang

iScience· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis